Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-129258

General Counsel sold 432 shares at $0.55 ($237)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-19 Sale : show line 1 in the form −432 $0.55 $237 211,499 D
Open-market sales · 432 sh · avg $0.55 · $237
Loading xslF345X05/ownership.xml…